Design, synthesis, and evaluation of chalcone-Vitamin E-donepezil hybrids as multi-target-directed ligands for the treatment of Alzheimer’s disease

References

• Barnett R. Alzheimer's disease. Lancet 2019;393:1589.
   PubMed Web of Science ®Google Scholar
• Patterson C. World Alzheimer Report 2018—the state of the art of dementia research: new frontiers. London: Alzheimer’s Disease International (ADI); 2018: 1–48.
   Google Scholar
• Citron M. Alzheimer's disease: strategies for disease modification. Nat Rev Drug Discov 2010;9:387–98.
   PubMed Web of Science ®Google Scholar
• Viña J, Sanz-Ros J. Alzheimer's disease: only prevention makes sense. Eur J Clin Invest 2018;48:e13005.
   PubMed Web of Science ®Google Scholar
• Jagust W. Imaging the evolution and pathophysiology of Alzheimer disease. Nat Rev Neurosci 2018;19:687–700.
   PubMed Web of Science ®Google Scholar
• Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002;297: 353–6.
   PubMed Web of Science ®Google Scholar
• Nalivaeva NN, Turner AJ. Targeting amyloid clearance in Alzheimer's disease as a therapeutic strategy. Br J Pharmacol 2019;176:3447–63.
   PubMed Web of Science ®Google Scholar
• Wang YJ. Alzheimer disease: lessons from immunotherapy for Alzheimer disease. Nat Rev Neurol 2014;10:188–9.
   PubMed Web of Science ®Google Scholar
• Cavalli A, Bolognesi ML, Minarini A, et al. Multi-target-directed ligands to combat neurodegenerative diseases. J Med Chem 2008;51:347–72.
   PubMed Web of Science ®Google Scholar
• Zhang P, Xu S, Zhu Z, Xu J. Multi-target design strategies for the improved treatment of Alzheimer's disease. Eur J Med Chem 2019;176:228–47.
   PubMed Web of Science ®Google Scholar
• de Freitas Silva M, Dias KST, Gontijo VS Jr., et al. Multi-target directed drugs as a modern approach for drug design towards Alzheimer's disease: an update. Curr Med Chem 2018;25:3491–525.
   PubMed Web of Science ®Google Scholar
• Lee S, Zheng X, Krishnamoorthy J, Savelieff MG, et al. Rational design of a structural framework with potential use to develop chemical reagents that target and modulate multiple facets of Alzheimer's disease. J Am Chem Soc 2014;136:299–310.
   PubMed Web of Science ®Google Scholar
• Li Q, He S, Chen Y, et al. Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease. Eur J Med Chem 2018;158:463–77.
   PubMed Web of Science ®Google Scholar
• Unzeta M, Esteban G, Bolea I, et al. Multi-target directed donepezil-like ligands for Alzheimer's disease. Front Neurosci 2016;10:205.
   PubMed Web of Science ®Google Scholar
• Anand A, Patience AA, Sharma N, Khurana N. The present and future of pharmacotherapy of Alzheimer's disease: a comprehensive review. Eur J Pharmacol 2017;815:364–75.
   PubMed Web of Science ®Google Scholar
• Cheignon C, Tomas M, Bonnefont-Rousselot D, et al. Oxidative stress and the amyloid beta peptide in Alzheimer's disease. Redox Biol 2018;14:450–64.
   PubMed Web of Science ®Google Scholar
• Doraiswamy PM, Finefrock AE. Metals in our minds: therapeutic implications for neurodegenerative disorders. Lancet Neurol 2004;3:431–4.
   PubMed Web of Science ®Google Scholar
• Dixon SJ, Stockwell BR. The role of iron and reactive oxygen species in cell death. Nat Chem Biol 2014;10:9–17.
   PubMed Web of Science ®Google Scholar
• Schedin-Weiss S, Inoue M, Hromadkova L, et al. Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels. Alzheimers Res Ther 2017;9:57.
   PubMed Web of Science ®Google Scholar
• Youdim MBH. Monoamine oxidase inhibitors, and iron chelators in depressive illness and neurodegenerative diseases. J Neural Transm 2018;125:1719–33.
   PubMed Web of Science ®Google Scholar
• Zhuang C, Zhang W, Sheng C, et al. Chalcone: a privileged structure in medicinal chemistry. Chem Rev 2017;117:7762–810.
   PubMed Web of Science ®Google Scholar
• Zhang X, Rakesh KP, Bukhari SNA, et al. Multi-targetable chalcone analogs to treat deadly Alzheimer's disease: current view and upcoming advice. Bioorg Chem 2018;80:86–93.
   PubMed Web of Science ®Google Scholar
• Sang Z, Wang K, Zhang P, et al. Design, synthesis, in-silico and biological evaluation of novel chalcone derivatives as multi-function agents for the treatment of Alzheimer's disease. Eur J Med Chem 2019;180:238–52.
   PubMed Web of Science ®Google Scholar
• Bai P, Wang K, Zhang P, et al. Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease. Eur J Med Chem 2019;183:111737.
   PubMed Web of Science ®Google Scholar
• Sang Z, Song Q, Cao Z, et al. Design, synthesis and evaluation of novel dimethylamino chalcone-O-alkylamines derivatives as potential multifunctional agents against Alzheimer's disease. Eur J Med Chem 2021;216:113310.
   PubMed Web of Science ®Google Scholar
• Lee GY, Han SN. The role of vitamin E in immunity. Nutrients 2018;10:1614.
   PubMed Web of Science ®Google Scholar
• Qiang X, Sang Z, Yuan W, et al. Design, synthesis and evaluation of genistein-O-alkylbenzylamines as potential multifunctional agents for the treatment of Alzheimer's disease. Eur J Med Chem 2014;76:314–31.
   PubMed Web of Science ®Google Scholar
• Sang Z, Qiang X, Li Y, et al. Design, synthesis and evaluation of scutellarein-O-alkylamines as multifunctional agents for the treatment of Alzheimer's disease. Eur J Med Chem 2015;94:348–66.
   PubMed Web of Science ®Google Scholar
• Sang Z, Wang K, Shi J, et al. The development of advanced structural framework as multi-target-directed ligands for the treatment of Alzheimer's disease. Eur J Med Chem 2020;192:112180.
   PubMed Web of Science ®Google Scholar
• Sang Z, Wang K, Shi J, et al. Apigenin-rivastigmine hybrids as multi-target-directed ligands for the treatment of Alzheimer's disease. Eur J Med Chem 2020;187:111958.
   PubMed Web of Science ®Google Scholar
• Wang LL, Du Y, Li SM, et al. Design, synthesis and evaluation of tetrahydrocarbazole derivatives as potential hypoglycemic agents. Bioorg Chem 2021;115:105172.
   PubMed Web of Science ®Google Scholar
• Sharma P, Tripathi A, Tripathi PN, et al. Design and development of multitarget-directed N-benzylpiperidine analogs as potential candidates for the treatment of Alzheimer's disease. Eur J Med Chem 2019;167:510–24.
   PubMed Web of Science ®Google Scholar
• Tripathi A, Choubey PK, Sharma P, et al. Design and development of molecular hybrids of 2-pyridylpiperazine and 5-phenyl-1,3,4-oxadiazoles as potential multifunctional agents to treat Alzheimer's disease. Eur J Med Chem 2019;183:111707.
   PubMed Web of Science ®Google Scholar
• Tripathi PN, Srivastava P, Sharma P, et al. Biphenyl-3-oxo-1,2,4-triazine linked piperazine derivatives as potential cholinesterase inhibitors with anti-oxidant property to improve the learning and memory. Bioorg Chem 2019;85:82–96.
   PubMed Web of Science ®Google Scholar
• Di L, Kerns EH, Fan K, et al. High throughput artificial membrane permeability assay for blood-brain barrier. Eur J Med Chem 2003;38:223–32.
   PubMed Web of Science ®Google Scholar
• Sang Z, Wang K, Bai P, et al. Design, synthesis and biological evaluation of novel O-carbamoyl ferulamide derivatives as multi-target-directed ligands for the treatment of Alzheimer's disease. Eur J Med Chem 2020;194:112265.
   PubMed Web of Science ®Google Scholar